Shandong Xinhua Pharmaceutical Co Ltd Working Capital to Net Assets Ratio
Shandong Xinhua Pharmaceutical Co Ltd working capital to net assets ratio. Shandong Xinhua Pharmaceutical Co Ltd (000756) has a Working Capital to Net Assets ratio of 15.7% as of June 2025. Working capital of CN¥839.89 Million (current assets of CN¥3.99 Billion minus current liabilities of CN¥3.15 Billion) is measured against net assets of CN¥5.36 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
Working capital to net assets ratio of Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024. This chart shows how Shandong Xinhua Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the ratio stands at 15.7%, reflecting working capital of CN¥839.89 Million against net assets of CN¥5.36 Billion CNY. Explore Shandong Xinhua Pharmaceutical Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Shandong Xinhua Pharmaceutical Co Ltd Working Capital to Net Assets Ratio by Year (2015–2024)
Shandong Xinhua Pharmaceutical Co Ltd working capital to net assets ratio by year from 2015 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 000756 current and non-current assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 17.8% | CN¥931.23 Million | CN¥5.22 Billion | CN¥3.73 Billion | CN¥2.80 Billion | ▲ +0.5 pp |
| 2023 | 17.3% | CN¥828.33 Million | CN¥4.78 Billion | CN¥3.31 Billion | CN¥2.49 Billion | ▲ +10.5 pp |
| 2022 | 6.9% | CN¥298.47 Million | CN¥4.35 Billion | CN¥3.46 Billion | CN¥3.16 Billion | ▼ 0.0 pp |
| 2021 | 6.9% | CN¥252.08 Million | CN¥3.65 Billion | CN¥2.75 Billion | CN¥2.50 Billion | ▼ -2.1 pp |
| 2020 | 9.0% | CN¥305.83 Million | CN¥3.39 Billion | CN¥2.69 Billion | CN¥2.38 Billion | ▲ +10.9 pp |
| 2019 | -1.8% | CN¥-57.13 Million | CN¥3.11 Billion | CN¥2.43 Billion | CN¥2.49 Billion | ▼ -2.6 pp |
| 2018 | 0.7% | CN¥20.45 Million | CN¥2.80 Billion | CN¥2.38 Billion | CN¥2.36 Billion | ▼ -19.4 pp |
| 2017 | 20.1% | CN¥519.15 Million | CN¥2.58 Billion | CN¥2.01 Billion | CN¥1.49 Billion | ▲ +47.1 pp |
| 2016 | -26.9% | CN¥-559.92 Million | CN¥2.08 Billion | CN¥1.71 Billion | CN¥2.27 Billion | ▼ -11.8 pp |
| 2015 | -15.1% | CN¥-299.44 Million | CN¥1.98 Billion | CN¥1.65 Billion | CN¥1.95 Billion | — |